Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,689.00
(
0.25%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: alternatepatel post# 211966

Tuesday, 06/20/2017 3:30:08 PM

Tuesday, June 20, 2017 3:30:08 PM

Post# of 257266
MYL—The Copaxone discussion starts at 21:03 remaining in the GS webcast. MYL’s CEO claims the FDA’s “information request” was only for the 20mg ANDA, but common sense tells us that the 40mg ANDA can’t be approved before the 20mg ANDA, so both ANDAs are delayed for all practical purposes.

Direct link to the webcast:
https://cc.talkpoint.com/gold006/061317a_as/

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today